Corneal Diseases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2016-07-25
EMA Refused: Dropcys (mercaptamine) — Lucane Pharma
The EMA refused marketing authorization for Dropcys (mercaptamine) by Lucane Pharma, for corneal diseases and cystinosis.